These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
495 related articles for article (PubMed ID: 28285784)
1. Pediatric Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States. Hsu DY; Brieva J; Silverberg NB; Paller AS; Silverberg JI J Am Acad Dermatol; 2017 May; 76(5):811-817.e4. PubMed ID: 28285784 [TBL] [Abstract][Full Text] [Related]
2. Morbidity and Mortality of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in United States Adults. Hsu DY; Brieva J; Silverberg NB; Silverberg JI J Invest Dermatol; 2016 Jul; 136(7):1387-1397. PubMed ID: 27039263 [TBL] [Abstract][Full Text] [Related]
3. Predictors of 30-day readmission in Stevens-Johnson syndrome and toxic epidermal necrolysis: A cross-sectional database study. Guzman AK; Zhang M; Kwatra SG; Kaffenberger BH J Am Acad Dermatol; 2020 Feb; 82(2):303-310. PubMed ID: 31542405 [TBL] [Abstract][Full Text] [Related]
4. Incidence, outcomes, and resource use in children with Stevens-Johnson syndrome and toxic epidermal necrolysis. Antoon JW; Goldman JL; Lee B; Schwartz A Pediatr Dermatol; 2018 Mar; 35(2):182-187. PubMed ID: 29315761 [TBL] [Abstract][Full Text] [Related]
5. A Retrospective Cohort Study of the Management and Outcomes of Children Hospitalized with Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis. Antoon JW; Goldman JL; Shah SS; Lee B J Allergy Clin Immunol Pract; 2019 Jan; 7(1):244-250.e1. PubMed ID: 29859332 [TBL] [Abstract][Full Text] [Related]
6. Incidence of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Nationwide Population-Based Study Using National Health Insurance Database in Korea. Yang MS; Lee JY; Kim J; Kim GW; Kim BK; Kim JY; Park HW; Cho SH; Min KU; Kang HR PLoS One; 2016; 11(11):e0165933. PubMed ID: 27835661 [TBL] [Abstract][Full Text] [Related]
7. Epidemiology of ophthalmologic disease associated with erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis in hospitalized children in the United States. Moreau JF; Watson RS; Hartman ME; Linde-Zwirble WT; Ferris LK Pediatr Dermatol; 2014; 31(2):163-8. PubMed ID: 23679157 [TBL] [Abstract][Full Text] [Related]
8. Life-threatening dermatoses: Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Impact on the Spanish public health system (2010-2015). Velasco-Tirado V; Alonso-Sardón M; Cosano-Quero A; Romero-Alegría Á; Sánchez-Los Arcos L; López-Bernus A; Pardo-Lledías J; Belhassen-García M PLoS One; 2018; 13(6):e0198582. PubMed ID: 29912947 [TBL] [Abstract][Full Text] [Related]
9. Genitourinary involvement and management in children with Stevens-Johnson syndrome and toxic epidermal necrolysis. Van Batavia JP; Chu DI; Long CJ; Jen M; Canning DA; Weiss DA J Pediatr Urol; 2017 Oct; 13(5):490.e1-490.e7. PubMed ID: 28314701 [TBL] [Abstract][Full Text] [Related]
10. Stevens-Johnson syndrome and toxic epidermal necrolysis in Hong Kong. Cheung CMT; Chang MM; Li JJX; Chan AWS Hong Kong Med J; 2024 Apr; 30(2):102-109. PubMed ID: 38531617 [TBL] [Abstract][Full Text] [Related]
11. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome. Yamane Y; Matsukura S; Watanabe Y; Yamaguchi Y; Nakamura K; Kambara T; Ikezawa Z; Aihara M Allergol Int; 2016 Jan; 65(1):74-81. PubMed ID: 26666483 [TBL] [Abstract][Full Text] [Related]
12. The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the UK. Frey N; Jossi J; Bodmer M; Bircher A; Jick SS; Meier CR; Spoendlin J J Invest Dermatol; 2017 Jun; 137(6):1240-1247. PubMed ID: 28202399 [TBL] [Abstract][Full Text] [Related]
13. Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective study. Barvaliya M; Sanmukhani J; Patel T; Paliwal N; Shah H; Tripathi C J Postgrad Med; 2011; 57(2):115-9. PubMed ID: 21654132 [TBL] [Abstract][Full Text] [Related]
14. Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry. Diphoorn J; Cazzaniga S; Gamba C; Schroeder J; Citterio A; Rivolta AL; Vighi GD; Naldi L; Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):196-203. PubMed ID: 26687641 [TBL] [Abstract][Full Text] [Related]
15. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children: 20 years study in a tertiary care hospital. Techasatian L; Panombualert S; Uppala R; Jetsrisuparb C World J Pediatr; 2017 Jun; 13(3):255-260. PubMed ID: 27650525 [TBL] [Abstract][Full Text] [Related]
16. Healthcare utilization and cost of Stevens-Johnson syndrome and toxic epidermal necrolysis management in Thailand. Dilokthornsakul P; Sawangjit R; Inprasong C; Chunhasewee S; Rattanapan P; Thoopputra T; Chaiyakunapruk N J Postgrad Med; 2016; 62(2):109-14. PubMed ID: 27089110 [TBL] [Abstract][Full Text] [Related]
17. Nationwide Survey of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children in the United States. Okubo Y; Nochioka K; Testa MA Pediatr Dermatol; 2017 Mar; 34(2):206-208. PubMed ID: 27990674 [TBL] [Abstract][Full Text] [Related]
18. 27 years of a single burn centre experience with Stevens-Johnson syndrome and toxic epidermal necrolysis: analysis of mortality risk for causative agents. Weinand C; Xu W; Perbix W; Lefering R; Maegele M; Rathert M; Spilker G Burns; 2013 Nov; 39(7):1449-55. PubMed ID: 23702222 [TBL] [Abstract][Full Text] [Related]
19. Nine years of a single referral center management of Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome). Monteiro D; Egipto P; Barbosa J; Horta R; Amarante J; Silva P; Silva A Cutan Ocul Toxicol; 2017 Jun; 36(2):163-168. PubMed ID: 27487073 [TBL] [Abstract][Full Text] [Related]
20. Toxic epidermal necrolysis and Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in pediatric patients with a focus on newer antiepileptic drugs: A 25-year retrospective study at a single tertiary care center. Gleghorn KL; Voigt C; Kelly B Pediatr Dermatol; 2021 Jul; 38(4):812-818. PubMed ID: 34060145 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]